|
|
|
51-200 employees
View all
|
|
biotechnology
|
|
25-28 North Wall Quay,Dublin,-,IE
|
|
Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of novel antibiotics to treat serious infections. Nabriva Therapeutics has two products: Xenleta (lefamulin), recently approved by the FDA for both Oral and IV use and CONTEPO (fosfomycin) for injection, we submitted an NDA for CONTEPO, a potential first-in-class epoxide antibiotic in the United States for complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP). Our corporate headquarters are in Dublin, Ireland with offices and labs located in Vienna, Austria and King of Prussia, PA.Nabriva is a commercial-stage biopharmaceutical company with locations in theUnited States (King of Prussia, PA, San Diego, CA), Austria (Vienna), and Ireland (Dublin), home of our corporate headquarters.
|
Nabriva Therapeutics plc Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
33.33%
|
The widely used Nabriva Therapeutics plc email format is {first}.{last} (e.g. [email protected]) with 33.33% adoption across the company.
To contact Nabriva Therapeutics plc customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.